Brian Slomovitz, MD of University of Miami Health System and Sylvester Comprehensive Cancer Center discusses the use of AIM2CERV’s axalimogene filolisbac for the treatment of HPV-associated cancers, including cervical cancer. This was recorded at the 2017 ASCO Annual Meeting in Chicago, IL.
Use of Axalimogene Filolisbac for Treatment of HPV-Associated Cancers
